{
    "2021-02-26": [
        [
            {
                "time": "",
                "original_text": "A股近一周牛熊股名单来了",
                "features": {
                    "keywords": [
                        "A股",
                        "牛熊股",
                        "名单"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药跌5.85% 节后市值蒸发434亿元 高瓴资本持股 连续下跌",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "跌幅",
                        "市值蒸发",
                        "高瓴资本",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "昭衍新药港股上市，第四家“A+H”CRO企业诞生！",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "港股上市",
                        "A+H",
                        "CRO企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)跌3.16%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "异动股",
                        "跌幅"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "120亿美元，ICON跃居全球CRO第二，开启远程CRO新赛点？",
                "features": {
                    "keywords": [
                        "ICON",
                        "CRO",
                        "全球第二",
                        "新赛点"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "太刺激！欧普康视领跌11%，通策医疗、爱尔眼科、泰格医药等医药龙头再度暴跌！ 连续下跌",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "通策医疗",
                        "爱尔眼科",
                        "泰格医药",
                        "医药龙头",
                        "暴跌",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年报及2021年一季报业绩前瞻：2020分化巨大 21Q1恢复良好",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2020年报",
                        "2021一季报",
                        "业绩前瞻",
                        "分化",
                        "恢复良好"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}